Risk stratification for early-onset fetal growth restriction in women with abnormal serum biomarkers: a retrospective cohort study
Abstract Abnormal maternal serum biomarkers (AMSB), identified through the aneuploidy screening programme, are frequent incidental findings in pregnancy. They are associated with fetal growth restriction (FGR), but previous studies have not examined whether this association is with early-onset (<...
Saved in:
Main Authors: | L. Ormesher, L. Warrander, Y. Liu, S. Thomas, L. Simcox, G. C. S. Smith, J. E. Myers, E. D. Johnstone |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/44e3d63be3224d5aa0a7a0b6bdae4348 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction
by: Tu’uhevaha J. Kaitu’u-Lino, et al.
Published: (2020) -
Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
by: Kamil Borkowski, et al.
Published: (2021) -
Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers
by: Maya H Buch, et al.
Published: (2021) -
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
by: Lewis J. Renshall, et al.
Published: (2021) -
Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis
by: Bo Yang, et al.
Published: (2021)